What are the treatment options for metastatic Multiple Myeloma

Treatment Options for Metastatic Multiple Myeloma

I appreciate your question. I want to clarify an important point about myeloma terminology first, then explain your treatment options.

Understanding "Metastatic" in Multiple Myeloma

Multiple myeloma is already a systemic (body-wide) cancer by definition. When myeloma is diagnosed, the cancer cells have typically already spread throughout the bone marrow and often to multiple bones in the body. So myeloma doesn't really have a "non-metastatic" stage the way some other cancers do.

What matters more for your treatment plan is:

• Whether it's newly diagnosed (primary/active myeloma)
• Whether it's relapsed or resistant (came back after treatment or stopped responding)
• Your risk category (standard risk vs. high risk based on genetic markers)

---

Primary Treatment Options (Newly Diagnosed)

According to NCCN Guidelines for Multiple Myeloma, the first-line treatment typically involves multi-drug combinations (3-4 medications together). Your specific combination depends on whether you're a candidate for a hematopoietic cell transplant (a procedure where high-dose chemotherapy is followed by healthy blood stem cell replacement).

Preferred Combinations:

If you may have a transplant:

• Daratumumab + bortezomib + lenalidomide + dexamethasone
• Bortezomib + lenalidomide + dexamethasone

If transplant is not planned:

• Daratumumab + lenalidomide + dexamethasone
• Isatuximab-irfc + bortezomib + lenalidomide + dexamethasone

Types of Medications Used:

These combinations typically include:

1. Targeted Therapy (Proteasome Inhibitors)

   • Bortezomib (Velcade)
   • Carfilzomib (Kyprolis)
   • Ixazomib (Ninlaro)
   • How they work: Block proteins that allow myeloma cells to survive

2. Immunomodulators

   • Lenalidomide (Revlimid)
   • Pomalidomide (Pomalyst)
   • Thalidomide (Thalomid)
   • How they work: Strengthen your immune system to fight cancer cells

3. Monoclonal Antibodies

   • Daratumumab (Darzalex)
   • Isatuximab-irfc (Sarclisa)
   • Elotuzumab (Empliciti)
   • How they work: Artificial antibodies that tag cancer cells for your immune system to attack

4. Corticosteroids

   • Dexamethasone (Decadron)
   • How they work: Reduce inflammation and help kill cancer cells

---

Treatment for Relapsed or Progressive Myeloma

If your myeloma comes back after initial treatment or stops responding, NCCN Guidelines recommend several options:

Preferred Multi-Drug Combinations for Previously Treated Myeloma:

• Daratumumab + bortezomib + dexamethasone
• Daratumumab + lenalidomide + dexamethasone
• Carfilzomib + lenalidomide + dexamethasone
• Isatuximab-irfc + carfilzomib + dexamethasone
• Pomalidomide + bortezomib + dexamethasone

Advanced Options (After Multiple Prior Treatments):

After trying 3-4 different therapies, NCCN Guidelines identify these as preferred options:

CAR T-Cell Therapy

• Abecma (idecabtagene vicleucel)
• Carvykti (ciltacabtagene autoleucel)
• How it works: Your own T cells (immune cells) are removed, genetically modified to recognize myeloma cells, then returned to your body to attack the cancer

Bispecific Antibodies (newer approach)

• Teclistamab-cqyv (Tecvayli)
• Talquetamab-tgvs (Talvey)
• Elranatamab-bcmm (Elrexfio)
• How they work: Attach to both your T cells AND myeloma cells, bringing them together so T cells can attack the cancer

---

Supportive Care (Part of All Treatment Plans)

Regardless of which drugs you receive, NCCN Guidelines recommend:

• Bone-building therapy (bisphosphonates or denosumab) to protect bones from damage
• Blood clot prevention if certain medications increase that risk
• Radiation therapy to reduce bone pain in specific areas
• Management of side effects like anemia, kidney problems, or infections

---

Key Factors Your Doctor Will Consider

Your treatment plan depends on:

• Your age and overall health
• Kidney and heart function
• Genetic markers of your myeloma (risk category)
• Whether you're eligible for stem cell transplant
• Your previous treatments (if any)
• Your personal goals and preferences

---

Important Questions to Ask Your Care Team

1. What is my myeloma's risk category, and what does that mean for my treatment?
2. Am I a candidate for a hematopoietic cell transplant? Why or why not?
3. Which drug combination do you recommend for me, and why?
4. What are the expected side effects of my specific treatment plan?
5. How will we measure if the treatment is working?
6. What happens if this treatment stops working?
7. Are there clinical trials available for my situation?
8. Should I get a second opinion from a myeloma specialist?

---

The Bottom Line

Multiple myeloma treatment has evolved dramatically, with many effective options available. According to NCCN Guidelines, the goal is to control the disease, improve symptoms, and maintain quality of life. If one treatment stops working, there are typically other options to try.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.